Medicine & Life Sciences
Anti-Bacterial Agents
40%
Burkholderia cepacia
21%
Carbapenem-Resistant Enterobacteriaceae
21%
Catheter-Related Infections
18%
Catheters
25%
Central Venous Catheters
27%
Cephalosporins
39%
Child
65%
Chlorhexidine
25%
chlorhexidine gluconate
20%
Clostridium difficile
18%
Cohort Studies
34%
Confidence Intervals
31%
Coronavirus
18%
Costs and Cost Analysis
20%
Cross Infection
50%
Disease Outbreaks
25%
Dysuria
18%
Enterobacteriaceae Infections
28%
Epidemiology
21%
Escherichia coli
20%
Gastroenteritis
20%
Hand Hygiene
41%
Human Influenza
20%
Infections
100%
Infectious Arthritis
18%
Intensive Care Units
21%
International Classification of Diseases
18%
Klebsiella pneumoniae
19%
Length of Stay
28%
Methicillin
35%
Methicillin Resistance
41%
Methicillin-Resistant Staphylococcus aureus
62%
Mupirocin
24%
Neonatal Intensive Care Units
71%
Odds Ratio
38%
Oseltamivir
19%
Osteomyelitis
29%
Paraspinal Muscles
19%
Pediatric Hospitals
27%
Pediatric Intensive Care Units
94%
Pediatrics
58%
posaconazole
20%
Prospective Studies
24%
Severe Acute Respiratory Syndrome
18%
Spinal Fusion
35%
Surgical Wound Infection
51%
temocillin
25%
Ureaplasma urealyticum
20%
Ventilator-Associated Pneumonia
36%